ARCHIVES

DeVita Suggest “Overlay Consortium” as Outreach Mechanism for Southern California, Other Areas

This article is from The Cancer Letter archive.

Vol. 10 No. 37 | September 28, 1984

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI

October 31, 2003

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991

Consructio Needs Over Next Five Years Total Estimated $696 Million; NCI Share-$132 Million

January 19, 1979

New Therapeutic Options Enhance Breast Cancer Treatment: ASCO Reports

July 26, 2002

ASC Survey Leads to Strategic Plan Development, Office In Washington

June 9, 1989

Senate Markup Would Give NCI $985 Million, Offers Prospect That Reductions In Grants Will Be Restored

December 10, 1982